Pharmacovigilance and Drug Safety Software Market to Reach Valuation of US$143.6 mn by 2022

Pharmacovigilance and Drug Safety Software Market Segmentation by Software - Adverse Event Reporting Software, Drug Safety Audits Software, Issue Tracking Software, and Fully Integrated Software; End User - Pharma and Biotech Companies, CROs, BPO Firms, and Pharmacovigilance Service Providers; Delivery Mode - Onpremise and Cloud-based and Forecast 2017 - 2022

Š2019 Transparency Market Research, All Rights Reserved

Sr. No.

Content

Chapter 1

Preface

Chapter 2

Assumptions and Research Methodology

Chapter 3

Market Overview

Chapter 4

Market Dynamics

Chapter 5

Global Pharmacovigilance and Drug Safety Software Market Analysis and Forecasts, By Software Type

Chapter 6

Global Pharmacovigilance and Drug Safety Software Market Analysis, by Modality

Chapter 7

Global Pharmacovigilance and Drug Safety Software Market Analysis, by Application

Chapter 8

Global Pharmacovigilance and Drug Safety Software Market Analysis, by End-user

Chapter 9

Global Pharmacovigilance and Drug Safety Software Market Analysis and Forecast by Region

Chapter 10

North America Pharmacovigilance and Drug Safety Software Market Analysis and Forecast

Chapter 11

Europe Pharmacovigilance and Drug Safety Software Market Analysis and Forecast

Chapter 12

Asia Pacific Pharmacovigilance and Drug Safety Software Market Analysis and Forecast

Chapter 13

Latin America Pharmacovigilance and Drug Safety Software Market Analysis and Forecast

Chapter 14

Middle East & Africa Pharmacovigilance and Drug Safety Software Market Analysis and Forecast

Chapter 15

Competition Landscape

Š2019 Transparency Market Research, All Rights Reserved



Pharmacovigilance is the profession of monitoring medical drug effects after being licensed.



The global pharmacovigilance and drug safety software market is envisioned to attract benefits while riding on the ability of products to avert, evaluate, and uncover enduring and temporary side effects of certain medications.



Pharmacovigilance software could help to inhibit unnecessary future events and determine the cause of withdrawal.



Companies are prominently enabled to put into practice proactive safety surveillance programs with the support provided by pharmacovigilance software as they push new limits in the market.

©2019 Transparency Market Research, All Rights Reserved



The global pharmacovigilance and drug safety software market to rise at a 5.4% CAGR between 2017 and 2022.



Rising withdrawals of high-profile drugs has been foretold to augment the employment of pharmacovigilance tools in the near future.



The usage of these tools could also gain growth because of the swelling pressure on drug manufacturers to determine early signs of adverse interactions due to drug consumption.



The demand in the world pharmacovigilance and drug safety software market could be bolstered with advancement in technology.



The top players of global pharmacovigilance and drug safety software market could be more into benefit due to the associated use of cutting-edge softwares like Argus and ARISg.



With easy accessible data and reduced use of outdated data, it has become easier for players to adopt pharmacovigilance softwares into the market.



Some of the leading players of the market are United BioSource Corporation, AB Cube, and UMBRA Global LLC.



Players could testify of quick business opportunities owing to the implementation of such strategies during their operation.

©2019 Transparency Market Research, All Rights Reserved

To know more about us, please visit our website www.transparencymarketresearch.com For sales queries or new topics email us on: sales@transparencymarketresearch.com

Thank You

Š2019 Transparency Market Research, All Rights Reserved